216 related articles for article (PubMed ID: 35896699)
1. DJ-1 controls T cell differentiation and osteoclastogenesis in rheumatoid arthritis.
Min HK; Kim SH; Lee JY; Lee SH; Kim HR
Sci Rep; 2022 Jul; 12(1):12767. PubMed ID: 35896699
[TBL] [Abstract][Full Text] [Related]
2. IL-18 binding protein suppresses IL-17-induced osteoclastogenesis and rectifies type 17 helper T cell / regulatory T cell imbalance in rheumatoid arthritis.
Min HK; Kim S; Lee JY; Kim KW; Lee SH; Kim HR
J Transl Med; 2021 Sep; 19(1):392. PubMed ID: 34530864
[TBL] [Abstract][Full Text] [Related]
3. Th17 cytokines regulate osteoclastogenesis in rheumatoid arthritis.
Kim KW; Kim HR; Kim BM; Cho ML; Lee SH
Am J Pathol; 2015 Nov; 185(11):3011-24. PubMed ID: 26362732
[TBL] [Abstract][Full Text] [Related]
4. TLR-3 enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis.
Kim KW; Cho ML; Oh HJ; Kim HR; Kang CM; Heo YM; Lee SH; Kim HY
Immunol Lett; 2009 May; 124(1):9-17. PubMed ID: 19446344
[TBL] [Abstract][Full Text] [Related]
5. Quercetin, a Plant Polyphenol, Has Potential for the Prevention of Bone Destruction in Rheumatoid Arthritis.
Kim HR; Kim BM; Won JY; Lee KA; Ko HM; Kang YS; Lee SH; Kim KW
J Med Food; 2019 Feb; 22(2):152-161. PubMed ID: 30596535
[TBL] [Abstract][Full Text] [Related]
6. N-acetyl-l-cysteine controls osteoclastogenesis through regulating Th17 differentiation and RANKL production in rheumatoid arthritis.
Kim HR; Kim KW; Kim BM; Lee KA; Lee SH
Korean J Intern Med; 2019 Jan; 34(1):210-219. PubMed ID: 28286938
[TBL] [Abstract][Full Text] [Related]
7. Promotion of osteoclastogenesis by IL-26 in rheumatoid arthritis.
Lee KA; Kim KW; Kim BM; Won JY; Min HK; Lee DW; Kim HR; Lee SH
Arthritis Res Ther; 2019 Dec; 21(1):283. PubMed ID: 31831038
[TBL] [Abstract][Full Text] [Related]
8. IL-32 and IL-17 interact and have the potential to aggravate osteoclastogenesis in rheumatoid arthritis.
Moon YM; Yoon BY; Her YM; Oh HJ; Lee JS; Kim KW; Lee SY; Woo YJ; Park KS; Park SH; Kim HY; Cho ML
Arthritis Res Ther; 2012 Nov; 14(6):R246. PubMed ID: 23148681
[TBL] [Abstract][Full Text] [Related]
9. Interleukin (IL)-25 suppresses IL-22-induced osteoclastogenesis in rheumatoid arthritis via STAT3 and p38 MAPK/IκBα pathway.
Min HK; Won JY; Kim BM; Lee KA; Lee SJ; Lee SH; Kim HR; Kim KW
Arthritis Res Ther; 2020 Sep; 22(1):222. PubMed ID: 32972460
[TBL] [Abstract][Full Text] [Related]
10. Tocotrienol regulates osteoclastogenesis in rheumatoid arthritis.
Kim KW; Kim BM; Won JY; Min HK; Lee SJ; Lee SH; Kim HR
Korean J Intern Med; 2021 Mar; 36(Suppl 1):S273-S282. PubMed ID: 32550719
[TBL] [Abstract][Full Text] [Related]
11. Rheumatoid and pyrophosphate arthritis synovial fibroblasts induce osteoclastogenesis independently of RANKL, TNF and IL-6.
Dickerson TJ; Suzuki E; Stanecki C; Shin HS; Qui H; Adamopoulos IE
J Autoimmun; 2012 Dec; 39(4):369-76. PubMed ID: 22867712
[TBL] [Abstract][Full Text] [Related]
12. Reciprocal activation of CD4+ T cells and synovial fibroblasts by stromal cell-derived factor 1 promotes RANKL expression and osteoclastogenesis in rheumatoid arthritis.
Kim HR; Kim KW; Kim BM; Jung HG; Cho ML; Lee SH
Arthritis Rheumatol; 2014 Mar; 66(3):538-48. PubMed ID: 24574213
[TBL] [Abstract][Full Text] [Related]
13. IL-23 induces receptor activator of NF-kappaB ligand expression in fibroblast-like synoviocytes via STAT3 and NF-kappaB signal pathways.
Li X; Kim KW; Cho ML; Ju JH; Kang CM; Oh HJ; Min JK; Lee SH; Park SH; Kim HY
Immunol Lett; 2010 Jan; 127(2):100-7. PubMed ID: 19900478
[TBL] [Abstract][Full Text] [Related]
14. Effects of IL-34 on the secretion of RANKL/OPG by fibroblast-like synoviocytes and peripheral blood mononuclear cells in rheumatoid arthritis.
Cui MY; Li X; Lei YM; Xia LP; Lu J; Shen H
Eur Cytokine Netw; 2019 Jun; 30(2):67-73. PubMed ID: 31486401
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-33 acts as a transcriptional repressor and extracellular cytokine in fibroblast-like synoviocytes in patients with rheumatoid arthritis.
Lee EJ; So MW; Hong S; Kim YG; Yoo B; Lee CK
Cytokine; 2016 Jan; 77():35-43. PubMed ID: 26520876
[TBL] [Abstract][Full Text] [Related]
16. Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappaB, osteoprotegerin, and receptor activator of nuclear factor kappaB ligand.
Lee CK; Lee EY; Chung SM; Mun SH; Yoo B; Moon HB
Arthritis Rheum; 2004 Dec; 50(12):3831-43. PubMed ID: 15593184
[TBL] [Abstract][Full Text] [Related]
17. Increased sensitivity of rheumatoid synoviocytes to Schnurri-3 expression in TNF-α and IL-17A induced osteoblastic differentiation.
Lavocat F; Osta B; Miossec P
Bone; 2016 Jun; 87():89-96. PubMed ID: 27072520
[TBL] [Abstract][Full Text] [Related]
18. RANKL expression in chondrocytes and its promotion by lymphotoxin-α in the course of cartilage destruction during rheumatoid arthritis.
Takeshita A; Nishida K; Yoshida A; Nasu Y; Nakahara R; Kaneda D; Ohashi H; Ozaki T
PLoS One; 2021; 16(7):e0254268. PubMed ID: 34234380
[TBL] [Abstract][Full Text] [Related]
19. Human rheumatoid synovial fibroblasts promote osteoclastogenic activity by activating RANKL via TLR-2 and TLR-4 activation.
Kim KW; Cho ML; Lee SH; Oh HJ; Kang CM; Ju JH; Min SY; Cho YG; Park SH; Kim HY
Immunol Lett; 2007 May; 110(1):54-64. PubMed ID: 17467812
[TBL] [Abstract][Full Text] [Related]
20. The effect of vascular endothelial growth factor on osteoclastogenesis in rheumatoid arthritis.
Kim HR; Kim KW; Kim BM; Cho ML; Lee SH
PLoS One; 2015; 10(4):e0124909. PubMed ID: 25894998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
